Inventiva S.A.
IVA Nasdaq Pharmaceutical Preparations Financials FY2018โFY2025
Last close ยท Oct 23, 2026
$3.71
3.1%
Revenue
Total sales reported in the income statement.
$5.1M
49.2%
vs prior year
Operating margin
Operating income as a share of revenue.
โ3,145.5%
2,084.8ย pts
Net income
Profit after all expenses, interest and tax.
โ$399M
Free cash flow
Cash from operations minus capital spending.
โ
Return on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
โ
Market cap
Last close times the latest diluted share count, so it is approximate.
$693M
Oct 23 close
P/E
Last close divided by diluted earnings per share over the last four quarters.
โ
On โ$2.14 EPS (TTM)
What Inventiva S.A. does
No business description yet.
- Legal name
- Inventiva S.A.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F ยท Apr 8, 2026
- Accession ยท CIK
- 0001104659-26-040704
0001756594
Revenue and margins
Inventiva S.A. had $5.1M of revenue in fiscal 2025, down 49.2% on the year before.
FY18
Revenue $3.8M
FY19
Revenue $7.8M
FY20
Revenue $0.4M
FY21
Revenue $5.0M
FY22
Revenue $12.8M
FY23
Revenue $18.9M
FY24
Revenue $10.0M
FY25
Revenue $5.1M
FY18
Gross โ
Operating โ1,029.2%
Net โ1,032.7%
FCF โ
FY19
Gross โ
Operating โ433.2%
Net โ431.8%
FCF โ
FY20
Gross โ
Operating โ7,988.8%
Net โ9,037.4%
FCF โ
FY21
Gross โ
Operating โ1,242.6%
Net โ1,183.5%
FCF โ
FY22
Gross โ
Operating โ468.9%
Net โ445.6%
FCF โ
FY23
Gross โ
Operating โ587.7%
Net โ631.8%
FCF โ
FY24
Gross โ
Operating โ1,060.6%
Net โ2,002.7%
FCF โ
FY25
Gross โ
Operating โ3,145.5%
Net โ7,899.5%
FCF โ
Gross
Operating
Net
FCF
Net income and earnings per share
Loss periods are shown in red.
FY18
Net income โ$39.0M
FY19
Net income โ$33.8M
FY20
Net income โ$38.3M
FY21
Net income โ$58.7M
FY22
Net income โ$57.0M
FY23
Net income โ$119M
FY24
Net income โ$199M
FY25
Net income โ$399M
FY18
Diluted EPS โ$1.90
FY19
Diluted EPS โ$1.43
FY20
Diluted EPS โ$1.13
FY21
Diluted EPS โ$1.50
FY22
Diluted EPS โ$1.38
FY23
Diluted EPS โ$2.63
FY24
Diluted EPS โ$3.33
FY25
Diluted EPS โ$2.14
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
FY18
Return on capital โ522.3%
Return on equity โ55.2%
Return on assets โ42.6%
FY19
Return on capital โ421.1%
Return on equity โ57.8%
Return on assets โ43.5%
FY20
Return on capital โ140.0%
Return on equity โ41.9%
Return on assets โ32.7%
FY21
Return on capital โ345.8%
Return on equity โ49.5%
Return on assets โ38.0%
FY22
Return on capital โ1,420.4%
Return on equity โ76.5%
Return on assets โ43.6%
FY23
Return on capital โ
Return on equity โ1,821.8%
Return on assets โ119.1%
FY24
Return on capital โ
Return on equity โ
Return on assets โ198.8%
FY25
Return on capital โ
Return on equity โ
Return on assets โ191.6%
Return on capital
Return on equity
Return on assets
Cash flow
Free cash flow was โ in fiscal 2025, โ of revenue. Cash from operations minus capital spending.
FY18
Free cash flow โ
FY19
Free cash flow โ
FY20
Free cash flow โ
FY21
Free cash flow โ
FY22
Free cash flow โ
FY23
Free cash flow โ
FY24
Free cash flow โ
FY25
Free cash flow โ
FY18
Cash from operations โ$40.4M
Capital spending โ
FY19
Cash from operations โ$31.8M
Capital spending โ
FY20
Cash from operations โ$34.9M
Capital spending โ
FY21
Cash from operations โ$56.3M
Capital spending โ
FY22
Cash from operations โ$47.2M
Capital spending โ
FY23
Cash from operations โ$88.3M
Capital spending โ
FY24
Cash from operations โ$93.0M
Capital spending โ
FY25
Cash from operations โ$118M
Capital spending โ
Cash from operations
Capital spending
Dividends, buybacks and share count
Inventiva S.A. returned โ to shareholders in fiscal 2025. The diluted share count rose 212.5%.
FY18
Dividends โ
Buybacks โ
FY19
Dividends โ
Buybacks โ
FY20
Dividends โ
Buybacks โ
FY21
Dividends โ
Buybacks โ
FY22
Dividends โ
Buybacks โ
FY23
Dividends โ
Buybacks โ
FY24
Dividends โ
Buybacks โ
FY25
Dividends โ
Buybacks โ
Dividends
Buybacks
FY18
Diluted shares 0.02B
FY19
Diluted shares 0.02B
FY20
Diluted shares 0.03B
FY21
Diluted shares 0.04B
FY22
Diluted shares 0.04B
FY23
Diluted shares 0.05B
FY24
Diluted shares 0.06B
FY25
Diluted shares 0.19B
Balance sheet
Cash, debt and the ratios that show how comfortably Inventiva S.A. can carry it.
FY18
Cash $64.9M
Debt $0.3M
FY19
Cash $40.3M
Debt $0.1M
FY20
Cash $130M
Debt $12.3M
FY21
Cash $98.0M
Debt $11.5M
FY22
Cash $92.5M
Debt $47.3M
FY23
Cash $29.7M
Debt $59.8M
FY24
Cash $100M
Debt โ
FY25
Cash $117M
Debt $70.3M
Cash
Debt
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $98.0M | $92.5M | $29.7M | $100M | $117M |
| Debt incl. finance leases | $11.5M | $47.3M | $59.8M | โ | $70.3M |
| Debt / equity | 0.1x | 1.0x | โ | โ | โ |
| Interest coverage | โ377.7x | โ97.8x | โ19.8x | โ8.0x | โ4.2x |
| Current ratio | 5.1x | 3.5x | 1.0x | 0.9x | 3.2x |
| Quick ratio | 5.0x | 3.5x | 1.0x | 0.9x | 3.2x |
| Total assets | $138M | $124M | $76.9M | $124M | $293M |
| Total liabilities | $37.5M | $75.2M | $112M | $234M | $327M |
| Shareholders' equity | $101M | $48.5M | โ$35.4M | โ$111M | โ$33.5M |
| Net debt (โ = net cash) | โ$86.6M | โ$45.2M | $30.0M | โ | โ$46.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 3 / 8 | 3 / 8 | 2 / 8 | 2 / 8 | 2 / 8 | 1 / 7 | 3 / 7 |
| Accruals ratio | 1.5% | โ2.6% | โ2.9% | โ1.5% | โ7.5% | โ31.1% | โ106.1% | โ134.9% |
| Altman Z'' | 4.00 | 1.53 | 7.71 | โ | โ | โ | โ | โ |
8 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $3.8M | $7.8M | $0.4M | $5.0M | $12.8M | $18.9M | $10.0M | $5.1M |
| Research and development | $37.5M | $37.8M | $27.0M | $57.3M | $63.6M | $119M | $98.3M | $98.2M |
| Operating income | โ$38.8M | โ$33.9M | โ$33.9M | โ$61.6M | โ$60.0M | โ$111M | โ$106M | โ$159M |
| Interest expense | $0.0M | $0.0M | $0.1M | $0.2M | $0.6M | $5.6M | $13.2M | $37.8M |
| Income tax | โ | $0.0M | $0.0M | $0.4M | โ$0.0M | $0.7M | $0.3M | $0.0M |
| Net income | โ$39.0M | โ$33.8M | โ$38.3M | โ$58.7M | โ$57.0M | โ$119M | โ$199M | โ$399M |
| Diluted EPS | โ$1.90 | โ$1.43 | โ$1.13 | โ$1.50 | โ$1.38 | โ$2.63 | โ$3.33 | โ$2.14 |
| Diluted shares | 0.02B | 0.02B | 0.03B | 0.04B | 0.04B | 0.05B | 0.06B | 0.19B |
| Cash flow | ||||||||
| Cash from operations | โ$40.4M | โ$31.8M | โ$34.9M | โ$56.3M | โ$47.2M | โ$88.3M | โ$93.0M | โ$118M |
| Stock-based compensation | $1.0M | $1.6M | $1.1M | $2.5M | $2.3M | $4.3M | $3.9M | $30.2M |
| Balance sheet | ||||||||
| Cash and short-term investments | $64.9M | $40.3M | $130M | $98.0M | $92.5M | $29.7M | $100M | $117M |
| Total debt | $0.3M | $0.1M | $12.3M | $11.5M | $47.3M | $59.8M | โ | $70.3M |
| Current assets | $82.0M | $54.9M | $163M | $131M | $113M | $53.2M | $116M | $287M |
| Current liabilities | $17.3M | $15.6M | $17.1M | $25.9M | $32.7M | $55.4M | $125M | $90.9M |
| Inventory | $0.5M | $0.4M | $0.4M | $0.4M | $0.4M | $0.5M | $0.0M | โ |
| Property and equipment, net | $5.2M | $4.2M | $4.0M | $3.6M | $7.9M | $10.1M | $5.2M | โ |
| Intangible assets | $1.8M | $1.4M | $1.1M | $0.9M | $0.6M | $0.6M | $0.0M | $0.2M |
| Total assets | $91.4M | $64.0M | $170M | $138M | $124M | $76.9M | $124M | $293M |
| Total liabilities | $20.9M | $17.5M | $34.0M | $37.5M | $75.2M | $112M | $234M | $327M |
| Shareholders' equity | $70.5M | $46.5M | $136M | $101M | $48.5M | โ$35.4M | โ$111M | โ$33.5M |
| Margins | ||||||||
| Operating margin | โ1,029.2% | โ433.2% | โ7,988.8% | โ1,242.6% | โ468.9% | โ587.7% | โ1,060.6% | โ3,145.5% |
| Net margin | โ1,032.7% | โ431.8% | โ9,037.4% | โ1,183.5% | โ445.6% | โ631.8% | โ2,002.7% | โ7,899.5% |
| Returns | ||||||||
| Return on capital | โ522.3% | โ421.1% | โ140.0% | โ345.8% | โ1,420.4% | โ | โ | โ |
| Return on capital employed | โ52.4% | โ70.1% | โ22.1% | โ54.9% | โ66.0% | โ518.0% | 5,758.9% | โ78.6% |
| Return on equity | โ55.2% | โ57.8% | โ41.9% | โ49.5% | โ76.5% | โ1,821.8% | โ | โ |
| Return on assets | โ42.6% | โ43.5% | โ32.7% | โ38.0% | โ43.6% | โ119.1% | โ198.8% | โ191.6% |
| Return on tangible equity | โ56.7% | โ75.0% | โ28.3% | โ58.8% | โ119.1% | โ | โ | โ |
| Growth | ||||||||
| Revenue growth | โ | 107.6% | โ94.6% | 1,069.8% | 158.1% | 47.7% | โ47.4% | โ49.2% |
| Share count change | โ | 14.5% | 44.0% | 15.6% | 5.8% | 9.4% | 31.8% | 212.5% |
| Financial health | ||||||||
| Debt / equity | 0.0x | 0.0x | 0.1x | 0.1x | 1.0x | โ | โ | โ |
| Interest coverage | โ8,260.7x | โ9,979.4x | โ450.4x | โ377.7x | โ97.8x | โ19.8x | โ8.0x | โ4.2x |
| Current ratio | 4.7x | 3.5x | 9.6x | 5.1x | 3.5x | 1.0x | 0.9x | 3.2x |
| Quick ratio | 4.7x | 3.5x | 9.5x | 5.0x | 3.5x | 1.0x | 0.9x | 3.2x |
| Capital allocation | ||||||||
| Stock comp / revenue | 26.1% | 20.1% | 252.1% | 49.8% | 18.2% | 22.7% | 38.9% | 597.1% |
| Quality scores | ||||||||
| Piotroski F-score | โ | 3.0 | 3.0 | 2.0 | 2.0 | 2.0 | 1.0 | 3.0 |
| Altman Z'' | 4.0 | 1.5 | 7.7 | โ | โ | โ | โ | โ |
| Accruals ratio | 1.5% | โ2.6% | โ2.9% | โ1.5% | โ7.5% | โ31.1% | โ106.1% | โ134.9% |
Source: SEC EDGAR XBRL filings (CIK 0001756594). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in EUR under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only โ not investment advice. Check the original filings before relying on any figure.